Alzamend Neuro (ALZN) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
Alzamend Neuro (ALZN) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Alzamend Neuro | 5.54 Mn | 5.54 Mn | - | 3.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 3.34 Mn |
| Jan 31, 2026 | 3.80 Mn |
| Oct 31, 2025 | 3.80 Mn |
| Jul 31, 2025 | 2.11 Mn |
| Apr 30, 2025 | 450,799.00 |
| Jan 31, 2025 | 733,049.00 |
| Oct 31, 2024 | 392,407.00 |
| Jul 31, 2024 | 95,703.00 |
| Apr 30, 2024 | 76,444.00 |
| Jan 31, 2024 | 73,541.00 |
| Oct 31, 2023 | 79,118.00 |
| Jul 31, 2023 | 71,810.00 |
| Apr 30, 2023 | 71,810.00 |
| Jan 31, 2023 | 71,431.00 |
| Oct 31, 2022 | 70,739.00 |
| Jul 31, 2022 | 70,730.00 |
| Apr 30, 2022 | 70,730.00 |
| Jan 31, 2022 | 66,745.00 |
| Oct 31, 2021 | 65,818.00 |
| Jul 31, 2021 | 64,364.00 |